Abstract
Accurate assessment of quality of life in patients with colorectal cancer is essential in order to inform clinical decisions by providing insights into patients’ experiences of the disease and treatment. This review summarizes the clinical evidence of how treatments for colorectal cancer impact on short- and long-term quality of life. Surgery for colorectal cancer has a short-term detrimental impact on most aspects of quality of life. Chemotherapy in palliative settings often preserves quality of life. Some studies do not demonstrate changes in keeping with clinical expectations. This may be due to insensitive quality of life tools, low numbers of patients, insufficient compliance or patients’ adaptation to changes. An international consensus involving clinicians and methodologists is needed to describe robust standards for quality of life measurement in oncology.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.